Atlas Trials

A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

Clinical trial NCT04483947 · COMPLETED

Trial details

NCT number
NCT04483947
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Non-alcoholic Steatohepatitis (NASH)
Start date
2020-11-06
Primary completion
2023-12-18
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.